Delivery Order SPE2DB22D3102-SPE2DB24FL2HZ
Award Date
8/5/24
Potential Completion Date
8/6/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,896.03 firm fixed-price contract is for the delivery of 4567829319 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, with a period of performance through April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ropivacaine 0.2% 400 mg/200 ml medical products. The order has a firm fixed price of $1,749.64 and a completion date of January 28, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,074.33 firm fixed-price contract is for the supply of 4567794869 - Ropivacaine 0.2% 200 mg/100 ml, 100 ml, with a completion date of April 4, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 400 mg/200 mL bottles of the pharmaceutical drug Ropivacaine 0.2%. The contract is a Delivery Order valued at $2,734.75 with a firm fixed price, and has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a ceiling value of $1,741.02 and a performance period that runs through April 2, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,633.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injections. The contract is a firm fixed-price, delivery order type with a completion date of February 25, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,513.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. It is a firm fixed-price delivery order contract with a period of performance through July 2024. This contract award is not designated as a set-aside and represents open competition. AmerisourceBergen also holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,567.82, is for the delivery of 400 mg/200 mL vials of the anesthetic drug ropivacaine 0.2%. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mg/200 mL ropivacaine 0.2% solution. The contract has a ceiling value of $15,136.95 and a period of performance through July 7, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 400 mg/200 mL of the pain medication Ropivacaine 0.2% in 200 mL doses. The contract has a ceiling value of $4,074.94 and is a firm fixed-price delivery order, with a completion date of June 13, 2025. The contract is not set-aside and is part of a larger $999,999,999.00...